Kontigo Care AB (KONT) AI Stock Analysis

• Market Cap: €70.86M
• Dividend Yield: N/A
• Average Volume (3M): 60.53K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.10
• Revenue Growth: -3.31%
• EPS Growth: -240.00%
• Country: SE
• Employees: 12
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): 0.03
• Shares Outstanding: 35,251,427
• 10 Day Avg. Volume: 76,444
• 30 Day Avg. Volume: 60,530
• PEG Ratio: 0.54
• Price to Book (P/B): 1.50
• Price to Sales (P/S): 2.60
• P/FCF Ratio: -14.03
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): €29.20M

• Rating: 52 Neutral
• Price Target: kr2.00 ▲(11.11% Upside)

Kontigo Care AB's overall stock score is primarily impacted by its financial performance, which is challenged by declining revenue growth and negative profitability. Technical analysis provides a slightly positive outlook, but valuation concerns due to a negative P/E ratio and lack of dividend yield weigh heavily on the score.

Positive Factors

Business Model

The subscription-based model provides a steady revenue stream, enhancing predictability and stability in financial planning.

Competitive Advantage

Specialization in addiction treatment offers a niche market advantage, allowing for tailored solutions and potential market leadership.

Balance Sheet Health

Low financial leverage indicates strong capital structure, reducing risk and increasing financial flexibility for future investments.

Negative Factors

Revenue Growth Challenges

Declining sales indicate potential market saturation or competitive pressures, requiring strategic adjustments to drive growth.

Profitability Concerns

Low profitability suggests inefficiencies in converting sales into profit, necessitating operational improvements for sustainable growth.

Cash Flow Issues

Negative cash flow growth highlights liquidity challenges, potentially limiting the ability to invest in growth opportunities.

Kontigo Care AB Business Overview & Revenue Model

Company Description

Kontigo Care AB (KONT) is a Swedish company specializing in digital health solutions focused on addiction treatment and recovery. The company operates primarily within the healthcare and technology sectors, providing innovative software and services designed to support individuals struggling with substance use disorders. Kontigo Care's core products include a digital platform that facilitates personalized treatment and recovery programs, leveraging data analytics and behavioral insights to enhance patient outcomes.

How the Company Makes Money

Kontigo Care generates revenue through multiple channels, primarily by offering subscription-based access to its digital health platform for healthcare providers and institutions. These subscriptions typically include features such as patient management tools, analytics, and therapeutic content tailored for addiction recovery. Additionally, the company may engage in partnerships with healthcare organizations, insurance companies, and government agencies, which can lead to revenue-sharing agreements or grants aimed at improving addiction treatment services. Furthermore, Kontigo Care may explore opportunities to license its technology or collaborate on research projects, contributing to its overall earnings.

Kontigo Care AB Financial Statement Overview

Summary

Kontigo Care AB faces financial challenges with declining revenue growth and negative profitability metrics. Despite a strong gross profit margin and stable balance sheet with low leverage, negative cash flow metrics and declining revenue growth are significant concerns.

Income Statement

Kontigo Care AB's income statement shows a mixed performance. The company has experienced a significant decline in revenue growth, with a TTM revenue growth rate of -55.7%. Profitability metrics such as the net profit margin and EBIT margin are negative, indicating operational challenges. However, the gross profit margin remains strong at over 100%, suggesting efficient cost management in production. The EBITDA margin is positive, reflecting some operational efficiency.

Balance Sheet

The balance sheet of Kontigo Care AB is relatively stable with a low debt-to-equity ratio of 0.047, indicating low financial leverage. However, the return on equity is negative in the TTM period, reflecting challenges in generating returns for shareholders. The equity ratio is healthy, suggesting a strong capital structure with stockholders' equity comprising a significant portion of total assets.

Cash Flow

Cash flow analysis reveals a challenging situation with a negative free cash flow growth rate of -278.6% in the TTM period. The operating cash flow to net income ratio is positive, indicating that operating activities are generating cash, but the free cash flow to net income ratio is negative, highlighting issues in converting earnings into free cash flow.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	29.11M	30.24M	28.95M	28.43M	24.54M	20.38M
Gross Profit	38.70M	40.08M	43.73M	28.24M	24.16M	20.01M
EBITDA	4.23M	5.07M	1.79M	4.13M	90.88K	2.20M
Net Income	-1.42M	775.00K	212.00K	2.90M	-1.20M	-1.28M
Balance Sheet
Total Assets	64.84M	67.74M	49.77M	31.39M	29.20M	24.46M
Cash, Cash Equivalents and Short-Term Investments	15.65M	21.86M	9.85M	5.74M	8.48M	4.94M
Total Debt	1.75M	3.67M	5.95M	0.00	1.08K	539.82K
Total Liabilities	13.13M	15.42M	19.05M	9.98M	10.74M	9.07M
Stockholders Equity	51.72M	52.32M	30.72M	21.40M	18.46M	15.40M
Cash Flow
Free Cash Flow	1.15M	-5.61M	-9.07M	-2.20M	272.26K	248.43K
Operating Cash Flow	5.58M	4.61M	5.97M	7.30M	4.61M	3.99M
Investing Cash Flow	-10.97M	-10.70M	-16.73M	-9.50M	-4.34M	-3.74M
Financing Cash Flow	7.68M	18.11M	14.87M	-540.00K	3.27M	-987.76K

Kontigo Care AB Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1.80
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:KONT, the sentiment is Negative. The current price of 1.8 is below the 20-day moving average (MA) of 1.94, below the 50-day MA of 1.90, and below the 200-day MA of 2.12, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 42.14 is Neutral, neither overbought nor oversold. The STOCH value of 4.43 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:KONT.

Kontigo Care AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
KONT	52 Neutral	€70.86M	―	-3.01%	―	-3.31%	-240.00%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
ONCOZ	41 Neutral	kr76.26M	―	-78.79%	―	―	20.55%
PTRK	41 Neutral	kr240.66M	-3.26	―	―	-8.33%	-329.50%
HEART	34 Underperform	kr143.96M	―	―	―	―	―
AINO	29 Underperform	€35.80M	―	-8607.90%	―	10.03%	66.78%